SC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel Disease
NCT00820365
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
34
Enrollment
INDUSTRY
Sponsor class
Conditions
Inflammatory Bowel Disease (IBD)
Interventions
DRUG:
SC12267 (4SC-101)
Sponsor
4SC AG